Citadel Advisors’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$492K Buy
21,800
+10,700
+96% +$246K ﹤0.01% 9360
2025
Q4
$264K Buy
+11,100
New +$276K ﹤0.01% 10420
2025
Q3
Sell
-15,000
Closed -$429K 13192
2025
Q2
$429K Sell
15,000
-19,000
-56% -$510K ﹤0.01% 8991
2025
Q1
$847K Buy
34,000
+10,100
+42% +$240K ﹤0.01% 7326
2024
Q4
$541K Sell
23,900
-32,600
-58% -$708K ﹤0.01% 8377
2024
Q3
$1.2M Buy
56,500
+19,100
+51% +$376K ﹤0.01% 6491
2024
Q2
$714K Buy
37,400
+31,100
+494% +$634K ﹤0.01% 7321
2024
Q1
$121K Buy
6,300
+5,200
+473% +$103K ﹤0.01% 11090
2023
Q4
$22.9K Sell
1,100
-18,200
-94% -$350K ﹤0.01% 12508
2023
Q3
$416K Sell
19,300
-12,800
-40% -$311K ﹤0.01% 8480
2023
Q2
$768K Buy
32,100
+8,300
+35% +$190K ﹤0.01% 7013
2023
Q1
$506K Buy
23,800
+4,300
+22% +$82.3K ﹤0.01% 8283
2022
Q4
$319K Buy
19,500
+6,200
+47% +$91.9K ﹤0.01% 9185
2022
Q3
$187K Sell
13,300
-3,100
-19% -$58.6K ﹤0.01% 10467
2022
Q2
$409K Buy
16,400
+4,500
+38% +$134K ﹤0.01% 9101
2022
Q1
$401K Buy
11,900
+4,200
+55% +$138K ﹤0.01% 9893
2021
Q4
$250K Buy
+7,700
New +$253K ﹤0.01% 11352

Other funds holding FMS

Citadel Advisors's FMS Position: Q1 2026 in Review

Citadel Advisors increased its Fresenius Medical Care (FMS) stake by 99% in Q1 2026, buying an estimated $645K and bringing the position to 56,578 shares worth $1.28M. The position accounts for ﹤0.01% of the portfolio, ranked #7123.

Citadel Advisors first reported a position in FMS in Q2 2016 and has held it in 36 quarters since. The position peaked at $16.3M in Q3 2022. 219 funds tracked by Wall St. Rank hold FMS as of Q1 2026.

  • Citadel Advisors held 56,578 shares of Fresenius Medical Care worth $1.28M as of Q1 2026.
  • Citadel Advisors bought 28,089 Fresenius Medical Care shares in Q1 2026, an estimated $645K.
  • Fresenius Medical Care made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #7123 holding.
  • Citadel Advisors first reported a position in Fresenius Medical Care in Q2 2016 and has held it in 36 quarters since.
  • Citadel Advisors's Fresenius Medical Care position peaked at $16.3M in Q3 2022.
  • 219 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.